mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0018 |
1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00035 |
1 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.4 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |